Clinical Trial

Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia

Study acronym: ThuLEP-BNI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the safety and effectiveness of different surgical treatments for men with small-volume benign prostatic hyperplasia (BPH). Men with small-volume BPH may still have bothersome lower urinary tract symptoms and bladder outlet obstruction, and the best surgical treatment for this group remains uncertain. In this multicentre, randomized, single-blind, four-arm controlled trial, 932 eligible men aged 40 to 80 years will be assigned in a 1:1:1:1 ratio to one of four groups: thulium laser enucleation of the prostate combined with bladder neck incision, thulium laser enucleation of the prostate alone, transurethral resection of the prostate (TURP), or transurethral incision of the prostate (TUIP). The main goal of the study is to compare the incidence of bladder neck contracture at 6 months after surgery. Secondary outcomes include safety outcomes and changes in urinary symptoms, urinary flow rate, pain score, and symptom response at 3 and 6 months after surgery. Exploratory outcomes include changes in post-void residual urine volume and sexual function scores. Additional exploratory long-term outcomes will also be assessed at 12 months after surgery.
Protocol Amendment History 6 changes
notable Enrollment increased: 615 -> 932 participants 2026-07-22
minor Trial arms changed: 3 -> 4 2026-07-22
notable Primary completion pushed: 2028-06 -> 2028-12 2026-07-22
minor Completion pushed: 2028-06 -> 2028-12 2026-07-22
critical Trial status changed: Recruiting → Not Yet Recruiting 2026-06-19
notable Enrollment increased: 426 -> 615 participants 2026-06-19
Trial Details
NCT Number NCT07569874
Lead Sponsor Chinese PLA General Hospital
Conditions Benign Prostatic Hyperplasia, Bladder Outlet Obstruction, Lower Urinary Tract Symptoms (LUTS)
Enrollment 932 participants
Start Date 2026-07
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-21